|
||||||||||||||||||||||||||||||||||
[發(fā)表評論] [本類其他產(chǎn)品] [本類其他供應(yīng)商] [收藏] |
銷售商: 上海皓元生物醫(yī)藥科技有限公司 | 查看該公司所有產(chǎn)品 >> |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 83898-65-1
MCE 國際站:Domperidone monomaleate
產(chǎn)品活性:Domperidone (R33812) monomaleate 是一種具有口服活性和選擇性的多巴胺-2 受體 (dopamine-2 receptor) 拮抗劑。Domperidone monomaleate 通過影響胃和小腸的化學(xué)感受器觸發(fā)區(qū)和運動功能,起到止吐和促動力劑作用。
研究領(lǐng)域:GPCR/G Protein | Neuronal Signaling
作用靶點:Dopamine Receptor
In Vitro: Cardiac Na+ channels are common targets of therapeutics inducing cardiotoxicity.
Domperidone monomaleate (0-1000 μM) displays concentration- and state-dependent inhibitory of Nav1.5 in Human embryonic kidney HEK293 cells.
Domperidone monomaleate (0, 10, 100 μM) displays tonic and use-dependent block to Na currents in rat cardiomyocytes with a IC50 of 312 μM.
In Vivo: Unlike Metoclopramide, Domperidone monomaleate does not cause any adverse neurological symptoms as it has minimal penetration through the blood-brain barrier.
Domperidone monomaleate acts as both an antiemetic and an upper gastrointestinal tract prokinetic agent. It is rapidly absorbed after oral administration, and few side effects have been reported.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Drug Repurposing Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Neurodegenerative Disease-related Compound Library | Rare Diseases Drug Library | Children’s Drug Library | Human Metabolite Library | Heterocyclic Compound Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Dopamine Receptor Compound Library | Clozapine N-oxide | MPTP hydrochloride | Oxidopamine hydrobromide | Chlorpromazine hydrochloride | L-DOPA | Dopamine hydrochloride | SCH-23390 hydrochloride | Haloperidol | Pimozide | SKF 38393 hydrochloride | Cabergoline | Risperidone | Olanzapine | Aripiprazole | Bromocriptine mesylate | Fluphenazine dihydrochloride | ONC206 | Thioridazine hydrochloride | Brexpiprazole | Flunarizine dihydrochloride | Sulpiride | Trifluoperazine dihydrochloride | WAY-100635 maleate | Quetiapine | Lurasidone | Nuciferine
熱門產(chǎn)品線:重組蛋白 | 藥物篩選 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球獨家化合物庫,我們致力于為全球科研客戶提供前沿最全的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng)域;
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥專利收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展,為您提供全球最新的活性化合物;
• 與世界各大制藥公司及知名科研機構(gòu)建立了長期的合作。